Psychiatry · Bozeman, MT
NPI
1083775035
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1871 S 22nd Ave Ste 3
Bozeman, MT, 59718
Phone (406) 585-3584
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$101K
806 prescriptions
Company payments, 2025
$14.72
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Thomas J Heriza prescribed most often to Medicare patients was Lamotrigine, with 92 prescriptions and refills. In total Thomas J Heriza wrote 806 Medicare prescriptions that cost $101K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-04.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Lamotrigine Generic | 92 | 188 | 16 | $810 |
| Gabapentin Generic | 58 | 79 | Under 11 | $469 |
| Quetiapine Fumarate Generic | 51 | 90 | Under 11 | $1,533 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 46 | 126 | Under 11 | $1,307 |
| Lorazepam Generic | 40 | 42 | Under 11 | $274 |
| Mirtazapine Generic | 34 | 75 | Under 11 | $831 |
| Nortriptyline Hcl Generic | 30 | 39 | Under 11 | $285 |
| Bupropion Hcl Sr Bupropion Hcl | 30 | 54 | Under 11 | $532 |
| Duloxetine Hcl Generic | 29 | 45 | Under 11 | $276 |
| Lithium Carbonate Er Lithium Carbonate | 26 | 42 | Under 11 | $306 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 22 | 28 | Under 11 | $498 |
| Clonazepam Generic | 22 | 26 | Under 11 | $147 |
| Alprazolam Generic | 19 | 24 | Under 11 | $67.29 |
| Trazodone Hcl Generic | 19 | 24 | Under 11 | $105 |
| Prazosin Hcl Generic | 18 | 25 | Under 11 | $392 |
Brand drugs: 36 claims; generic drugs: 770 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas J Heriza $14.72 ($14.72 in general payments such as food, travel and fees) from 1 company. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $14.72.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $14.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.